There are two clinically available markers that enable the detection of the development and progression of DN: the degree of albuminuria by using the albumin–creatinine ratio (ACR) and the estimated glomerular filtration rate (eGFR) calculated using the Chronic Kidney Disease Epidemiology Collaboration (CKD-EPI) method [14]. Here, ALB is linked to liver dysplastic nodule.